All Curated Mutation Sites in HBV 
Back to Mutation Home

 The Virus Mutation(VM) module provides researchers the annotations of reported pathogenic mutations in HBV related to human diseases. The curated VM information includes mutation site, mutation level, virus gene/protein/region, virus-associated disease, genotype/subtype, literature evidence, etc.


Browse Data by Virus Gene/Protein/Region, Disease OR Description
*Please select one option you are interested in, the page will be automatically redirected.
     
     

For highly variable viruses (e.g., HBV, HIV, SARS-CoV-2), ViMIC defaults to displaying mutations in a specific region. Click the green button to search for other regions, or click "Show All" to view all mutations (loading speed may be affected by network conditions).

Show All
  
S
  
BCP
  
X
  
C
  
Core Promoter
  
Core Upstream Regulatory Sequence
  
DR1
  
EnhI
  
EnhII
  
PreC
  
P
  
PreC Promoter
  
PreS
  
PreS1
  
PreS1 Promoter
  
PreS2
  
RT
  
S Promoter
  
S1 Promoter
  
S2 Promoter
  
X Promoter
  

Keyword: Hepatitis B, Chronic-16428891
ID PMID Mutation Gene/Protein/Region Encoding Gene/Protein Disease Description Detail
1 16428891 S135F
RT
P
Hepatitis B, Chronic
G
C
L
View
2 16428891 M204I
RT
P
Hepatitis B, Chronic
G
C
L
View
3 16428891 H216H
P
P
Hepatitis B, Chronic
G
C
L
View
4 16428891 W196X
S
S
Hepatitis B, Chronic
G
C
L
View
5 16428891 G700A
RT
P
Hepatitis B, Chronic
G
C
L
View
6 16428891 V191I
RT
P
Hepatitis B, Chronic
G
C
L
View
7 16428891 L229G
P
P
Hepatitis B, Chronic
G
C
L
View
8 16428891 W182X
S
S
Hepatitis B, Chronic
G
C
L
View
9 16428891 A128V
S
S
Hepatitis B, Chronic
G
C
L
View
10 16428891 C221G
S
S
Hepatitis B, Chronic
G
C
L
View
11 16428891 F219S
S
S
Hepatitis B, Chronic
G
C
L
View
12 16428891 F220L
S
S
Hepatitis B, Chronic
G
C
L
View
13 16428891 I195M
S
S
Hepatitis B, Chronic
G
C
L
View
14 16428891 I208T
S
S
Hepatitis B, Chronic
G
C
L
View
15 16428891 S193L
S
S
Hepatitis B, Chronic
G
C
L
View
16 16428891 S207R
S
S
Hepatitis B, Chronic
G
C
L
View
17 16428891 S210E
S
S
Hepatitis B, Chronic
G
C
L
View
18 16428891 T189I
S
S
Hepatitis B, Chronic
G
C
L
View
19 16428891 V190A
S
S
Hepatitis B, Chronic
G
C
L
View
20 16428891 W196L
S
S
Hepatitis B, Chronic
G
C
L
View
21 16428891 P127S
S
S
Hepatitis B, Chronic
G
C
L
View
22 16428891 P120S
S
S
Hepatitis B, Chronic
G
C
L
View
23 16428891 S143L
S
S
Hepatitis B, Chronic
G
C
L
View
24 16428891 C533T
S
S
Hepatitis B, Chronic
G
C
L
View
25 16428891 A739G
S
S
Hepatitis B, Chronic
G
C
L
View
26 16428891 A773C
P
P
Hepatitis B, Chronic
G
C
L
View
27 16428891 C136C
P
P
Hepatitis B, Chronic
G
C
L
View
28 16428891 C198C
P
P
Hepatitis B, Chronic
G
C
L
View
29 16428891 C512T
S
S
Hepatitis B, Chronic
G
C
L
View
30 16428891 C537T
P
P
Hepatitis B, Chronic
G
C
L
View
31 16428891 C582T
P
P
Hepatitis B, Chronic
G
C
L
View
32 16428891 C720T
P
P
Hepatitis B, Chronic
G
C
L
View
33 16428891 C732T
P
P
Hepatitis B, Chronic
G
C
L
View
34 16428891 C772T
P
P
Hepatitis B, Chronic
G
C
L
View
35 16428891 E215S
P
P
Hepatitis B, Chronic
G
C
L
View
36 16428891 F151F
P
P
Hepatitis B, Chronic
G
C
L
View
37 16428891 F201F
P
P
Hepatitis B, Chronic
G
C
L
View
38 16428891 F227F
P
P
Hepatitis B, Chronic
G
C
L
View
39 16428891 G741A
S
S
Hepatitis B, Chronic
G
C
L
View
40 16428891 G741T
S
S
Hepatitis B, Chronic
G
C
L
View
41 16428891 G783A
S
S
Hepatitis B, Chronic
G
C
L
View
42 16428891 H197H
P
P
Hepatitis B, Chronic
G
C
L
View
43 16428891 M204V
P
P
Hepatitis B, Chronic
G
C
L
View
44 16428891 S219A
P
P
Hepatitis B, Chronic
G
C
L
View
45 16428891 T138I
P
P
Hepatitis B, Chronic
G
C
L
View
46 16428891 T723C
P
P
Hepatitis B, Chronic
G
C
L
View
47 16428891 T777C
P
P
Hepatitis B, Chronic
G
C
L
View
48 16428891 T784G
S
S
Hepatitis B, Chronic
G
C
L
View
49 16428891 T810C
P
P
Hepatitis B, Chronic
G
C
L
View
50 16428891 T814G
S
S
Hepatitis B, Chronic
G
C
L
View
51 16428891 T815G
S
S
Hepatitis B, Chronic
G
C
L
View
Contents
Description

The table shows all curated mutation sites of HBV in each literature

Table Description Column Note
D
The study mentioned a certain treatment method, such as drug resistance caused by mutations.
G
The study mentioned the virus genotype/subtype information.
R
The study mentioned the reference sequence used for comparison, or the original strain of the virus used for site-directed mutagenesis.
S
The study provided sequence information or accession numbers.
L
The study provided the geographic region/country of data origin.
C
The study provided clinical baseline information.
I
The study involved information related to immune.
T
The study involved host target genes.